Dr Marzieh Amirmostofian
Research Associate
School of Pharmacy and Biomedical Science
College of Health
| Year | Citation |
|---|---|
| 2025 | Abid, F., Kim, S., Savaliya, B., Cesari, L., Amirmostofian, M., Abdella, S., . . . Garg, S. (2025). Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.. International journal of nanomedicine, 2025(20), 2181-2204. Scopus3 WoS3 Europe PMC1 |
| 2024 | Youssef, S. H., Ganesan, R., Amirmostofian, M., Kim, S., Polara, R., Afinjuomo, F., . . . Garg, S. (2024). Printing a Cure: A Tailored Solution for Localized Drug Delivery in Liver Cancer Treatment.. International journal of pharmaceutics, 651(123790), 123790. Scopus7 WoS6 Europe PMC6 |
| 2023 | Abid, F., Savaliya, B., Parikh, A., Kim, S., Amirmostofian, M., Cesari, L., . . . Garg, S. (2023). Nanotechnology and narasin: a powerful combination against acne.. Nanoscale, 15(33), 13728-13739. Scopus8 WoS7 Europe PMC5 |
| 2023 | Amirmostofian, M., Akbari, F., Hashemzaei, M., Safaeinejad, F., Tabrizian, K., Arbab, H., . . . Shahraki, J. (2023). Hormetic effects of curcumin on oxidative stress injury induced by trivalent arsenic in isolated rat hepatocytes. Avicenna Journal of Phytomedicine, 13(6), 641-650. Scopus4 WoS3 Europe PMC3 |
| 2023 | Meakin, A. S., Amirmostofian, M., Darby, J. R., Holman, S. L., Morrison, J. L., & Wiese, M. D. (2023). Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes. Placenta, 131, 82-89. Scopus3 WoS3 Europe PMC2 |
| 2017 | Nazari, P., Bazi, A., Ayatollahi, S. A., Dolati, H., Mahdavi, S. M., Rafighdoost, L., & Amirmostofian, M. (2017). Synthesis and evaluation of the antimicrobial activity of spiro-4H-pyran derivatives on some gram positive and gram negative bacteria. Iranian Journal of Pharmaceutical Research, 16(3), 943-952. Scopus26 WoS26 Europe PMC11 |
| 2017 | Entezari Heravi, Y., Sereshti, H., Saboury, A. A., Ghasemi, J., Amirmostofian, M., & Supuran, C. T. (2017). 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole–benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 688-700. Scopus23 WoS21 Europe PMC11 |
| 2015 | Amirmostofian, M., Kobarfard, F., Reihanfard, H., Mashayekhi, V., & Zarghi, A. (2015). Design, synthesis and cytotoxicity evaluationof new 1,2-diaryl-4, 5, 6, 7-tetrahydro-1h-benzo[d] imidazolesas tubulin inhibitors. Iranian Journal of Pharmaceutical Research, 14(1), 59-65. Scopus2 WoS2 Europe PMC1 |
| 2013 | Amirmostofian, M., Jaktaji, J. P., Soleimani, Z., Tabib, K., Tanbakosazan, F., Omrani, M., & Kobarfard, F. (2013). Synthesis and Molecular-cellular Mechanistic Study of Pyridine Derivative of Dacarbazine. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 12(3), 255-265. WoS10 Europe PMC7 |
| 2009 | Pourahmad, J., Amirmostofian, M., Kobarfard, F., & Shahraki, J. (2009). Biological reactive intermediates that mediate dacarbazine cytotoxicity. Cancer Chemotherapy and Pharmacology, 65(1), 89-96. Scopus61 WoS55 Europe PMC41 |
| Year | Citation |
|---|---|
| 2021 | Rajkumar, R., Robinson, J., Amirmostofian, M., Kahn, M. S., Mackenzie, L., Roberts, M. S., . . . Roberts, D. (2021). Prescribing implications of measured concentrations of apixaban in a geriatric inpatient population. In AUSTRALASIAN JOURNAL ON AGEING Vol. 40 (pp. 26). WILEY. |